Enhancing Oral Solid Dose Solubility And Bioavailability With Amorphous Solid Dispersions (ASD)


Pharmaceutics International, Inc. (Pii) will accelerate your early development through clinical studies for challenging, complex oral solid dose formulations with state-of-the-art spray drying technology.

Solubility and bioavailability are inherent challenges in the early stages of development for oral solid dose pharmaceuticals. Struggling to overcome these hurdles can cost drug sponsors precious time and resources and ultimately place their commercialization hopes at risk, as well as, the hopes of patients depending on new therapies to treat their disease or illness.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma

Pharmaceutics International